TNH Hospital Group: Former Chairman Hoang Tuyen Exits Entire 3.2% Stake at Record Low
This Aveluro analysis covers TNH on HOSE in the Health Care sector. The classified event type is stake change, with negative sentiment and a deterministic market-impact score of 4.0/10. Aveluro classifies this story as a negative catalyst and risk signal for the affected stock. Source coverage came from CafeF - Thị trường chứng khoán, classified as a primary/top-tier source.
Key Facts
Caveat: Not investment advice. · How Aveluro computed this: Aveluro combines extracted event facts, source credibility, ticker context, and market data. Scores are deterministic research signals, not recommendations.
Overview
Hoang Tuyen, a board member and former chairman of CTCP Tap doan Benh vien TNH (HOSE: TNH), completed the sale of his entire 3.2% stake, more than 5.31 million shares, between 11 September and 8 October 2026. The disposal, made via negotiated and order-matched methods, ends a multi-year exit from a holding that stood near 10% of the company in early 2024. It coincides with TNH shares touching VND 5,660, their lowest level since listing on the Ho Chi Minh City exchange.
Key Facts
- Hoang Tuyen sold more than 5.31 million TNH shares, equal to 3.2% of charter capital, from 11 September to 8 October 2026.
- Post-transaction ownership fell to 0%; he is no longer a direct shareholder of TNH.
- He held close to 10% of TNH in early 2024, gifting 3 million shares (1.5 million each) to his children Hoang Anh and Hoang Tung, both of whom later sold out.
- In August 2025 he sold 5 million shares, cutting his stake to 3.2% and dropping below the major-shareholder threshold; a bonus-share issue lifted his holding to over 5.31 million shares before the final sale.
- TNH traded from roughly VND 8,000 per share in early September to an all-time low of VND 5,660, and closed at VND 6,500 on 12 October 2026.
- Hoang Tuyen served as TNH chairman from 2013 until April 2026, when Nguyen Thi Thuy Giang replaced him; in September 2026 Le Xuan Tan was elected chairman and Giang became CEO.
- Reviewed H1 2026 consolidated results show net revenue of more than VND 276 billion; the article does not disclose the transaction value of the stake sale.
What Happened
According to a company disclosure on the share transactions of Hoang Tuyen, a board member and former chairman, the sale was executed through both put-through and order-matching trades. The filing confirms his ownership ratio dropped to zero, formally ending his tenure as a shareholder after more than a decade of association with the hospital chain he helped list on HOSE.
The exit follows a staged reduction. After gifting shares to his two children in 2024, both recipients sold their holdings. Hoang Tuyen then sold 5 million shares in August 2025, falling below the 5% major-shareholder mark, and the remaining position was enlarged by a bonus-share issuance before being fully liquidated in the September-October 2026 window. The article attributes the timing to heavy selling pressure on TNH, which has drifted from around VND 8,000 in early September to a record low of VND 5,660 before a partial recovery.
Market Context
TNH is listed on HOSE in the healthcare sector, a segment that has drawn only limited foreign and institutional flows relative to Vietnamese banking, real estate and retail names. The stock closed at VND 6,500 on 12 October 2026, still close to its post-listing trough, reflecting persistent selling pressure rather than a single-event reaction. The broader Vietnamese market has been sensitive to liquidity and interest-rate conditions, and small-cap hospital operators with expansion plans have underperformed larger, cash-generative healthcare peers.
Strategic Significance
The departure of a founder-chairman who guided TNH from 2013 through its listing removes a long-standing insider anchor from the shareholder register at a moment when the company is asking investors to back a convertible bond issuance. For long-term holders, the key question is whether the new leadership under chairman Le Xuan Tan and CEO Nguyen Thi Thuy Giang can fund hospital-network expansion without diluting equity at depressed valuations. The convertible bond plan, to be tabled at the first extraordinary general meeting of 2026, is the clearest signal of how management intends to bridge that funding gap.
What to Watch
- The extraordinary general meeting, expected in late October or early November 2026, and the terms of the convertible bond issuance.
- Details of the shareholder list finalised on 9 October 2026, including any new institutional or foreign holders.
- Full-year 2026 financial statements for evidence that hospital-network expansion is translating into revenue growth beyond the VND 276 billion booked in H1.
- Further board or management changes following the September 2026 leadership reshuffle.
- Trading volume and price behaviour around the VND 5,660 post-listing low as a gauge of whether selling pressure has exhausted.